Cite
MLA Citation
Rachel L Sabado et al.. “Phase I/II study of Resiquimod as an immunologic adjuvant for NY-ESO-1 protein vaccination in patients with melanoma.” Journal for immunotherapy of cancer, vol. 1, n.d., p. . http://access.bl.uk/ark:/81055/vdc_100135570771.0x000002